ZANNI, MANUELA
ZANNI, MANUELA
High CR Rate and Prolonged EFS in aaIPI 2 – 3 Diffuse Large B-Cell Lymphoma Following High-Dose Sequential Chemotherapy and In Vivo Rituximab-Purged Stem Cell Autografting (R-HDS Regimen): Results of a Prospective Phase II Multicenter Study Sponsored by GITIL (Gruppo Italiano Terapie Innovative nei Linfomi)
2005-01-01 Corrado Tarella; Manuela Zanni; Massimo Di Nicola; Caterina Patti; Claudia Castellino; Alessandra Pescarollo; Valerio Zoli; Daniele Caracciolo; Marco Ladetto; Michele Magni; Liliana Devizzi; Mario Boccadoro; Marco Bregni; Paolo Corradini; Andrea Gallamini; Ignazio Majolino; Salvo Mirto; Alessandro M. Gianni
Incidence and Risk-Factors of Secondary Myelodysplastic Syndrome/Acute Leukemia Following High-Dose Chemotherapy and Autograft: A Long-Term Analysis on 307 Lymphoma Patients
2004-01-01 Davide Bono; Manuela Zanni; Irene Ricca; Daniele Caracciolo; Elisa Dama; Corrado Magnani; Paolo Gavarotti; Luciana Bergui; Alessandra Cuttica; Marco Ladetto; Mario Boccadoro; Dario Ferrero; Corrado Tarella
Non-Hodgkin’s Lymphoma Refractory to First Line Therapy: Incidence, Associated Clinical and Histological Factors, and Outcome among 503 Newly Diagnosed Patients
2007-01-01 Angela Gueli; Daniele Caracciolo; Manuela Zanni; Luciana Bergui; Paolo Gavarotti; Marco Ladetto; Andrea Filippi; Roberto Passera; Mario Boccadoro; Corrado Tarella
Progressive Telomere Shortening Is Part of the Natural History of Chronic Lymphocytic Leukemia (CLL) and Impacts Clinical Outcom
2011-01-01 Elisa Bernocco; Davide Rossi; Elisa Genuardi; Chiara Lobetti-Bodoni; Roberto Passera; Daniela Drandi; Marta Coscia; Marina Ruggeri; Marco Fangazio; Paola Ghione; Daniela Barbero; Barbara Mantoan; Sara Barbiero; Manuela Zanni; Valter Gattei; Luciana Bergui; Paola Omedè; Massimo Massaia; Mario Boccadoro; Gianluca Gaidano; Marco Ladetto
Progressive telomere shortening occurs during the natural history of chronic lymphocytic leukemia (CLL) and associates to outcome
2011-01-01 Bernocco E; Rossi D; Genuardi E; Lobetti-Bodoni C; Drandi D; Coscia M; Ruggeri M; Fangazio M; Ghione P; Antico O; Zanni M; Gattei V; Bergui L; Omedè P; Massaia M; Boccadoro M; Gaidano G; Ladetto M
Rituximab-Supplemented High-Dose Sequential (HDS) Chemotherapy with Autograft Is Highly Effective in High-Risk (aaIPI 2–3) Diffuse Large B-Cell Lymphoma: Results of a Prospective Multicenter Study on 91 Consecutive Patients Treated at Diagnosis
2004-01-01 Manuela Zanni; Massimo Di Nicola; Caterina Patti; Claudia Castellino; Alessandra Pescarollo; Valerio Zoli; Daniele Caracciolo; Michele Magni; Liliana Devizzi; Mario Boccadoro; Ignazio Majolino; Marco Bregni; Andrea Gallamini; Salvo Mirto; Marco Ladetto; Alessandro M. Gianni; Corrado Tarella
Telomere Length of Hematopoietic Cells Following Autologous and Allogeneic Stem Cell Transplant (SCT) Reflects That of Grafted Cells: Can the Transplant of Younger Stem Cells Be Exploited To Rejuvenate Hematopoiesis?
2007-01-01 Alberto Rocci; Marco Ruella; Irene Ricca; Cristiana Carniti; Manuela Zanni; Chiara Lobetti Bodoni; Marco Ladetto; Daniele Caracciolo; Mario Boccadoro; Paolo Corradini; Corrado Tarella
TELOMERES SHORTEN DURING CHRONIC LYMPHOCYTIC LEUKEMIA(CLL) EVOLUTION: AN ANALYSIS ON 88 CASES
2012-01-01 E Genuardi; E Bernocco; D Rossi; C Lobetti-Bodoni; P Ghione; R Bruna; D Drandi; M Coscia; M Ruggeri; M Fangazio; L Monitillo; D Barbero; B Mantoan; S Barbiero; M Zanni; V Gattei; L Bergui; P Omedè; M Massaia; M Boccadoro; G Gaidano; M Ladetto
The Degree of Telomere Loss in Hematopoietic Cells Correlates with the Risk of Secondary Myelodysplasia/Acute Leukemia Development Following Autologous Stem Cell Transplantation
2007-01-01 Irene Ricca; Alberto Rocci; Marco Ruella; Manuela Zanni; Daniele Caracciolo; Marco Ladetto; Mario Boccadoro; Dario Ferrero; Corrado Tarella
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| High CR Rate and Prolonged EFS in aaIPI 2 – 3 Diffuse Large B-Cell Lymphoma Following High-Dose Sequential Chemotherapy and In Vivo Rituximab-Purged Stem Cell Autografting (R-HDS Regimen): Results of a Prospective Phase II Multicenter Study Sponsored by GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) | 2005 | Corrado Tarella; Manuela Zanni; Massimo Di Nicola; Caterina Patti; Claudia Castellino; Alessandra Pescarollo; Valerio Zoli; Daniele Caracciolo; Marco Ladetto; Michele Magni; Liliana Devizzi; Mario Boccadoro; Marco Bregni; Paolo Corradini; Andrea Gallamini; Ignazio Majolino; Salvo Mirto; Alessandro M. Gianni | |
| Incidence and Risk-Factors of Secondary Myelodysplastic Syndrome/Acute Leukemia Following High-Dose Chemotherapy and Autograft: A Long-Term Analysis on 307 Lymphoma Patients | 2004 | Davide Bono; Manuela Zanni; Irene Ricca; Daniele Caracciolo; Elisa Dama; Corrado Magnani; Paolo Gavarotti; Luciana Bergui; Alessandra Cuttica; Marco Ladetto; Mario Boccadoro; Dario Ferrero; Corrado Tarella | |
| Non-Hodgkin’s Lymphoma Refractory to First Line Therapy: Incidence, Associated Clinical and Histological Factors, and Outcome among 503 Newly Diagnosed Patients | 2007 | Angela Gueli; Daniele Caracciolo; Manuela Zanni; Luciana Bergui; Paolo Gavarotti; Marco Ladetto; Andrea Filippi; Roberto Passera; Mario Boccadoro; Corrado Tarella | |
| Progressive Telomere Shortening Is Part of the Natural History of Chronic Lymphocytic Leukemia (CLL) and Impacts Clinical Outcom | 2011 | Elisa Bernocco; Davide Rossi; Elisa Genuardi; Chiara Lobetti-Bodoni; Roberto Passera; Daniela Drandi; Marta Coscia; Marina Ruggeri; Marco Fangazio; Paola Ghione; Daniela Barbero; Barbara Mantoan; Sara Barbiero; Manuela Zanni; Valter Gattei; Luciana Bergui; Paola Omedè; Massimo Massaia; Mario Boccadoro; Gianluca Gaidano; Marco Ladetto | |
| Progressive telomere shortening occurs during the natural history of chronic lymphocytic leukemia (CLL) and associates to outcome | 2011 | Bernocco E; Rossi D; Genuardi E; Lobetti-Bodoni C; Drandi D; Coscia M; Ruggeri M; Fangazio M; Ghione P; Antico O; Zanni M; Gattei V; Bergui L; Omedè P; Massaia M; Boccadoro M; Gaidano G; Ladetto M | |
| Rituximab-Supplemented High-Dose Sequential (HDS) Chemotherapy with Autograft Is Highly Effective in High-Risk (aaIPI 2–3) Diffuse Large B-Cell Lymphoma: Results of a Prospective Multicenter Study on 91 Consecutive Patients Treated at Diagnosis | 2004 | Manuela Zanni; Massimo Di Nicola; Caterina Patti; Claudia Castellino; Alessandra Pescarollo; Valerio Zoli; Daniele Caracciolo; Michele Magni; Liliana Devizzi; Mario Boccadoro; Ignazio Majolino; Marco Bregni; Andrea Gallamini; Salvo Mirto; Marco Ladetto; Alessandro M. Gianni; Corrado Tarella | |
| Telomere Length of Hematopoietic Cells Following Autologous and Allogeneic Stem Cell Transplant (SCT) Reflects That of Grafted Cells: Can the Transplant of Younger Stem Cells Be Exploited To Rejuvenate Hematopoiesis? | 2007 | Alberto Rocci; Marco Ruella; Irene Ricca; Cristiana Carniti; Manuela Zanni; Chiara Lobetti Bodoni; Marco Ladetto; Daniele Caracciolo; Mario Boccadoro; Paolo Corradini; Corrado Tarella | |
| TELOMERES SHORTEN DURING CHRONIC LYMPHOCYTIC LEUKEMIA(CLL) EVOLUTION: AN ANALYSIS ON 88 CASES | 2012 | E Genuardi; E Bernocco; D Rossi; C Lobetti-Bodoni; P Ghione; R Bruna; D Drandi; M Coscia; M Ruggeri; M Fangazio; L Monitillo; D Barbero; B Mantoan; S Barbiero; M Zanni; V Gattei; L Bergui; P Omedè; M Massaia; M Boccadoro; G Gaidano; M Ladetto | |
| The Degree of Telomere Loss in Hematopoietic Cells Correlates with the Risk of Secondary Myelodysplasia/Acute Leukemia Development Following Autologous Stem Cell Transplantation | 2007 | Irene Ricca; Alberto Rocci; Marco Ruella; Manuela Zanni; Daniele Caracciolo; Marco Ladetto; Mario Boccadoro; Dario Ferrero; Corrado Tarella |